Seliciclib

An orally available small molecule and cyclin-dependent kinase (CDK) inhibitor with potential apoptotic and antineoplastic activity. CDKs, serine/threonine kinases that play an important role in cell cycle regulation, are overexpressed in various malignancies. Seliciclib primarily inhibits CDK 2, 7, and 9 by competing for the ATP binding sites on these kinases, leading to a disruption of cell cycle progression. In addition, this agent seems to interfere with CDK-mediated phosphorylation of the carboxy-terminal domain of RNA polymerase II, thereby inhibiting RNA polymerase II-dependent transcription. This may lead to the down-regulation of anti-apoptotic factors, such as myeloid cell leukemia sequence 1 (Mcl-1), a protein crucial for the survival of a range of tumor cell types. The down-regulation of anti-apoptotic factors may lead to an induction of apoptosis, thereby further contributing to seliciclib's antiproliferative effects. (NCI Thesaurus)

YOU MAY ALSO LIKE

Self-Report

An individual's perspective or subjective interpretation of an event or information.

Self-Organizing Map

A data visualization technique which reduces the dimensions of data through the use of self-organizing neural networks. SOMs scale well to large…

Self-harm

Self-harm refers to a person's harming their own body on purpose. About 1 in 100 people hurts himself or herself in…

Self-Examination

The inspection of one's own body, usually for signs of disease.

Self-Etching Bonding System

Using an acid to condition tooth dentin, resulting in a superficial demineralization of dentin, allowing a low-viscosity monomer to be diffused into…

Self-esteem

A feeling of self-worth, self-confidence, and self-respect.